Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic <i>EGFR</i>-Mutant Lung Cancers

Helena A. Yu, Mark G. Kris, Adam J. Schoenfeld et al.|JAMA Oncology|2020

Cited by 131